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Abstract 
Human induced pluripotent stem cells (hiPSC) have transformed 
research since their discovery. The hiPSC technology enables detailed 
cellular studies on pathogenic processes in patient-derived somatic cell 
types that are specifically affected by the disease of the patient. 
However, due to the fact that these somatic cells are effectively 
rejuvenated during the iPSC reprogramming process, they have been 
considered less suitable for pathogenic studies on late-onset diseases, 
such as Parkinson’s disease. We introduce a human in-vitro model to 
accelerate ageing of the iPSC-derived somatic cells using transgenic 
expression of progerin. Before application to our PD patient-derived DA 
neurons, we have chosen to test and implement our progerin-associated 
ageing model on embryonic stem cell differentiated cardiomyocytes. 
These cells can be easily differentiated, have a large soma easily 
accessible for microscopic analysis and display high mitochondrial 
activity allowing accurate evaluation of aging hallmarks. Differentiated 
cells that express progerin indeed displayed several hallmarks of ageing, 
including nuclear folding, chromosomal instability and mitochondrial 
dysfunction. Crucially, compared to earlier work by other groups, we can 
sustain progerin expression for up to at least 30 days, without apparent 
toxicity associated with the method for transgenic expression. Progerin-
induced ageing on Parkinson’s disease patient hiPSC-derived 
dopaminergic neurons resulted in neuronal cells with increased amounts 
of α-synuclein compared to control populations. This chapter presents 




Age-associated diseases pose an increasing burden on society 
and are often related to cellular senescence. Hallmarks of ageing are 
currently considered to be comprised of genomic instability, telomere 
attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient 
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sensing, mitochondrial dysfunction, cellular senescence, stem cell 
exhaustion, and altered intercellular communication [1]. To properly 
model these processes in an ageing model for cell culture applications, 
scientists have come up with a number of ways to recapitulate parts of 
the ageing process. But, while most models mimic one hallmark of 
ageing, it remains difficult to tackle the multiple aspects of the ageing 
process. Cell models for late onset disorders, such as Parkinson’s 
disease (PD), often use mitochondrial toxins [2-4], proteasome inhibitors 
[5], mimicking only part of the ageing process. Apart from this, cell 
models often consist of immortalized proliferating cells [6, 7], which are 
vastly different from somatic cells and make it difficult to model a 
senescent cell.  
The use of human induced pluripotent stem cells (hiPSCs) and 
human embryonic stem cells (hESCs) has overcome part of this 
challenge since they can be differentiated into lineage-specific cells with 
a low mitotic index. However, reprogramming of somatic cells into iPSCs 
leads to their rejuvenation [8]. Telomere elongation, increased 
mitochondrial fitness and chromatin remodelling effectively restore 
iPSCs to an embryonic state that is beneficial for stemness. Thus, the 
reprogramming event also reverses several hallmarks of ageing making 
the resulting differentiated cells less suitable for modelling age-related 
disorders. Direct reprogramming of somatic cells is one way to 
overcome these challenges [9], but resulting cells are often unlike their 
somatic counterparts [10], and present epigenetic marks of the original 
cells after transdifferentiation [11].  
An alternative method to overcome these challenges is using a 
mutated protein of Hutchinson-Gilford progeria syndrome (HGPS), a rare 
autosomal dominant disorder involving a splice variant of the LMNA 
gene [12]. The LMNA G608G (GGC>GGT) mutation in exon 11 activates 
a cryptic splice site leading to an aberrant form of the Lamin A/C protein, 
named progerin. Affected cells display a multiple hallmarks of ageing 
including nuclear deformation, DNA damage and mitochondrial 
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dysfunction [13]. Affected individuals usually die in the second decade of 
life from disorders usually associated with an aged population. Mental 
development is unaffected, and patients show no predisposition of 
neurodegeneration. This is due to a lack of Lamin A expression in the 
brain, where Lamin B and Lamin C are predominantly expressed [14].  
Using progerin in a cell culture model for ageing has previously 
been introduced by Miller et al. [15], where it was elegantly shown that 
cells could be aged using progerin. However, procedural limitations 
prevented cells to be cultured for more than five days after progerin 
expression. Using modified RNA, cells were put under high transfection 
stress, resulting in major cell death even in the control group. To 
circumvent this problem, we decided to devise a lentiviral approach to 
expose cells to prolonged progerin expression.  
This model has been extensively tested on hESC-derived 
cardiomyocytes (hESC-CMs), since LMNA laminopathies are usually 
associated with cardiac disease [16]. Furthermore, cardiac cells have 
high mitochondrial activity and are relatively easy to differentiate [17, 
18].  By using the cardiac expression pattern during differentiation, 
transgenic progerin expression can be achieved using a conditional 
promoter. The ability to use cardiac cells at 30 days in vitro (DIV) 
compared to neurons at 60 DIV, allows for optimization of the method in 
a disease relevant cell type. After introduction and evaluation of the 
model in cardiomyocytes, we have used the same model on PD patient-
derived neurons obtained via iPSC differentiation, to use it as a model 
for ageing.  
In this chapter, we show that lentivirus-induced progerin 
expression in ESC-derived CMs leads to increased mitochondrial stress, 
nuclear deformation and an increase in double stranded break (DSB) 
formation of DNA. Additionally, we improved this ageing model for CMs 
by introducing a conditional promoter system for cardiac cell specific 
expression of progerin. Progerin expression in PD iPSC-derived 
neuronal cells leads to a typical accumulation of α-synuclein, a hallmark 
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of altered proteostasis not seen in control transduced PD iPSC-derived 
neuronal cells.  
 
Materials and Methods  
Culture of hESCs and hiPSCs  
Human iPSCs were generated using a protocol described in 
chapter 3 of this thesis. Human HUES9 embryonic stem cells were 
provided by Harvard University HSCI iPS Core Facility.  
Geltrex®-coated plates and Essential 8™ medium (Thermo Fisher 
Scientific) were used to maintain cells according to the manufacturer’s 
instruction. Passaging of iPSCs was done using ReLeSR™ (Stemcell 
Technologies) according to the manufacturer’s instruction, while 
passaging of ESCs was done using TrypLE™ Express (Thermo Fisher 
Scientific). All cells were maintained in a humidified incubator at 37°C with 
5%CO2. ESCs were used below passage 50, while iPSCs were used 
between passage 25 and 35.  
 
Dopaminergic differentiation  
Dopaminergic differentiation was achieved using a slightly 
adapted protocol from Kriks et al. [19], described in chapter 3 of this 
thesis. At day 20 of differentiation, cells were dissociated with Accutase 
(Sigma-Aldrich) and plated on Geltrex®-coated tissue culture treated 
plates. To purify cultures, cultures were exposed to glucose deprivation 
and lactate (5mM) supplementation (GDLS) at 26 days in vitro (DIV) after 
which neurons were maintained to 60 DIV. At 60DIV, transduction was 
performed after which cells were cultured for 30 DIV.  
 
Cardiac differentiation  
CMC differentiation of ESCs was achieved by dissociating HUES9 
ESCs with 1x TrypLE Express for 4 minutes and plating them as single 
cells in Essential 8 medium containing 5 μM Y26732 (Selleck Chemicals). 
Once cultures reached 80% confluency, cells were washed with PBS and 
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differentiation was initiated (day 0) by culturing cells in RPMI1640 medium 
(Thermo Fisher Scientific) supplemented with 1x B27 minus insulin 
(Thermo Fisher Scientific) and 6 μM CHIR99021 (Cayman Chemical). At 
day 2, cells were washed with PBS and medium was refreshed with 
RPMI1640 supplemented with 1x B27 minus insulin and 2 μM Wnt-C59 
(Tocris Bioscience). From day 4, medium was changed to CDM3 [17] 
medium and refreshed every other day as CM maintenance medium. This 
resulted in cultures with >90% spontaneously contracting CM at day 8-10. 
To further enrich these cultures, starting from day 12, differentiated CM 
were cultured in glucose-free RPMI1640-based (Thermo Fisher Scientific) 
CDM3 medium supplemented with 5 mM sodium DL-lactate (Sigma-
Aldrich) for 6-10 days [20]. At 20DIV, medium was supplemented with 
triiodothyronine (Sigma-Aldrich) to enhance cardiomyocyte maturation 
and increase MYH6 expression [21].  
 
Vector construction  
PCR amplification (Phusion High-Fidelity DNA Polymerase, 
Thermo Fisher Scientific) for AcGFP and AcGFP-progerin (a generous gift 
by Justine Miller) with overhangs for SpeI and KpnI was performed, and 
purified fragments were ligated in CloneJET vector (Thermo Fisher 
Scientific).  Resulting CloneJET vectors and the pSin-EF2-Nanog-Pur 
vector (addgene plasmid 16578) were restricted using BcuI (SpeI, Thermo 
Fisher Scientific) and KpnI (Thermo Fisher Scientific), subsequently 
ligated using T4 ligase (Thermo Fisher Scientific) after which the product 
was transformed in DH5α competent cells. Colony PCR screening was 
performed to select positive colonies, which were checked by restriction 
analysis. Correct plasmids were sent for sequencing and transfected in 
HEK293T to validate expression.  
A conditional vector for AcGFP and AcGFP-progerin expression 
was created at Oxford Genetics. To achieve expression, inserts were 
placed under control of the α-MHC promoter, which is flanked by an 
EF1a-PuroR cassette to allow puromycin selection of transduced cells. 
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The cassette is flanked by a Woodchuck Hepatitis Virus (WHP) 
Posttranscriptional Regulatory Element (WPRE) for stable expression of 
the transgenes. 
Viral transduction 
Viral transduction was using a slightly modified protocol by Trono 
et al. (Production and titration of lentiviral vectors) achieved by 
transfecting a T75 of HEK-293T cells when cells were 70-80% confluent. 
A mixture containing 900 µl OPTIMEM (Thermo Fisher Scientific) 9 µg 
viral vector, 3 µg pMD2-VSV-G and 7.5 µg pCMV-D8.91, was 
supplemented with 45 µl FUGENE HD (Lonza) and incubated for 15 min 
at room temperature (RT) to generate transfection complexes. The next 
day medium was changed with 20 ml RPMI 1640 (Thermo Fisher 
Scientific) and viral particles were harvested between 36 and 48 h. Viral 
supernatant was collected and sterilized using a 0.45 µm filter 
(Nalgene), subsequently mixed with CDM3 in a 1:1 ratio for AcGFP-
progerin, and a 1:4 ratio for AcGFP. The resulting mixture was 
supplemented with polybrene (8 µg/ml). HUES9 derived CMs were 
dissociated using 1x TrypLE Express, spun down at 200g, resuspended 
in low volume and added to the viral mixture. The next day cells were 
washed with dPBS, and medium was changed to CDM3.  
Transducing HUES9 ES cells with the conditional promoter 
system was achieved using a similar protocol as described above, with 
minor modifications. HEK293T cells were transfected with the pSF-OxG-
Lenti-aMHC-AcGFP-(Progerin)-Puro-WPRE vector, constructed by 
Oxford Genetics custom cloning and viral supernatant was collected in 
E8 medium w/o supplement. After transduction, HUES9 cells were 
cultured with 50μg puromycin to obtain clones with similar integration 
profiles. Resulting cultures were single cell sorted using a flow cytometer 






Borosilicate glass coverslips containing cells were fixed in 
paraformaldehyde 4% for 15 min at room temperature and stored at 4°C. 
Permeabilization and blocking were done in PBS containing 0.1% Triton, 
1% BSA and 5% normal goat serum for ~60 min at RT. Primary antibody 
incubation was done overnight at 6°C, followed by three PBS washes (5 
min each), after which a fluorescent conjugated secondary antibody and 
Hoechst 33258 (Sigma-Aldrich, 14530) were added. Mowiol® 4-88 
(Sigma-Aldrich) was used as mounting medium to attach the coverslips to 
glass slides. Samples were stored at 4°C until further analysis. Primary 
antibodies used were monoclonal anti-α-actinin IgG1 (1:100; A7811, 
Sigma-Aldrich), polyclonal anti-cardiac troponin T IgG (1:100; ab45932, 
Abcam) polyclonal anti-TOM20 IgG (1:250; sc-11415, Santa Cruz 
Biotech), monoclonal Anti-phospho-Histone H2A.X (Ser139) (1:100, clone 
JBW301, Millipore).  
 
Imaging  
Phase contrast imaging was performed on a Leica AF-6000 
microscope, using a 20x objective (PL FLUOTAR 20x/NA 0.4, Dry).  
Confocal images were acquired using a Leica SP8 confocal 
microscope, equipped with an HC PLAPO CS2 63x oil lens, with NA 1.4. 
Epifluorescence images were acquired using a Leica AF-6000 fluorescent 
microscope, using a PL FLUOTAR 20x/NA 0.4, Dry lens.  
 
CellROX™ assay  
 To perform CellROX™ (Thermo Fisher Scientific) assays, cells 
were plated and transduced in a Geltrex®-coated 96 well plate. After two 
weeks of transgenic expression, medium was changed to CDM3 without 
phenol red 2 hours prior to measurement. For measurement, 25μl of 
CDM3 without phenol red supplemented with 5μM CellROX™ orange and 
10mM HEPES was added to the wells. Fluorescent signal (Ex/Em: 
540/570) was measured every minute for 2h by a SYNERGY H1 plate 
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reader (BIOTEK), and the area under curve (AUC) was calculated from 
the resulting data. Experiments were performed in n=5 independent 
differentiations.  
 
Genomic DNA qPCR 
 Single cell sorted HUES9 clones were expanded for two 
passages, and genomic DNA was extracted using a QIAamp DNA Mini 
Kit (QIAGEN). In order to find the right conditions for qPCR on gDNA, 
primer test experiments were performed for the GAPDH (Fw: 
GGCTCCCACCTTTCTCATCC, Rev: CTCCCCACATCACCCCTCTA) and 
AcGFP (Fw: CGAGCTGAATGGCGATGTGA, Rev: 
CCGGTGGTGCAGATGAACT) primer using different primer concentrations, 
and different input of genomic DNA. Using this data, we determined the 
optimal concentration to compare the amount of AcGFP integration 
between clones. To determine the amount of integration samples were 
mixed with primers (5nM) and IQ SYBR Green (170-8885, BioRad). 
Samples were run on a Biorad C1000 Touch thermal cycler and analyzed 
with Biorad CFX managerTM software. 
 
Statistical analysis 
All statistical tests were performed using Prism 7.0. Statistical 
significance was determined using one-way ANOVA followed by Tukey 
post hoc test. A p value < 0.05 was considered significant. With biological 
replicates lower than n=3 no significance was indicated.  
 
Results 
To introduce viral expression of AcGFP and AcGFP-progerin, 
several vectors were used. To introduce progerin expression in initial 
experiments, a vector with a strong promoter and easy vector design was 
chosen to directly transduce differentiated cardiomyocytes. After initial 
findings a second expression system was introduced, using conditional 
promoter driven expression of AcGFP and AcGFP-progerin. This design 
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enables the study of clonal lines, allowing more stable expression 
between control and progerin expressing lines and takes away the need 
for directly transducing differentiated cultures.  
 
HUES9 CMs can be successfully transduced by an AcGFP-progerin 
viral vector 
Construction of the viral vector was based on the pSinEF2 vector with 
AcGFP or AcGFP-progerin placed under expression of the EF1a promoter 
(Figure 1A). Testing of the vector in HEK293T cells showed a robust 
expression of the viral vector (Figure 1B). Additionally, CMs were 
transduced successfully (Figure 1C). Transgenic AcGFP-progerin 
expression showed progerin localisation around the nuclear lamina 
(Figure 1C). 
   
Figure 1. AcGFP-progerin can be successfully expressed in CMs. (A) Vector 
map of the pSinEF2-AcGFP-progerin viral vector. AcGFP-progerin is placed 
under control of the EF1-α promoter. (B) HEK293T cells expressing the AcGFP-
progerin vector. (C) CMC cultures successfully transduced by AcGFP-Progerin. 
Striated α-actinin structures (red), AcGFP-progerin and Hoechst (blue) are shown 
at 40DIV. All bars represent 25 µm. 
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Progerin expression leads to oxidative stress  
AcGFP-progerin-expressing CMs produced significantly more 
ROS compared to AcGFP expressing and control CMs. Figure 2A 
displays fluorescent images of measured CMs. The amount of transduced 
cells was similar between AcGFP and AcGFP-progerin. Expression of 
AcGFP-progerin showed a significant increase (19.4%) in ROS 
production compared to control (p<0.0001) and to AcGFP-expressing 
CMs (p<0.0001) (Figure 2B).  
 
Figure 2. AcGFP-progerin expression leads to an increase in ROS 
production. (A) Transduction with AcGFP and AcGFP-progerin vectors. AcGFP-
progerin co-localizes with the nuclear membrane, while AcGFP is expressed 
diffusely in the cytoplasm. Scalebar represents 25 µm. (B) ROS production is 
higher in AcGFP-progerin expressing cells (19.4% increase), while it remains 
similar between control and AcGFP (2.1%, n.s.). All data were produced with n=5 
biological replicates.  
 
Progerin expression leads to an increase in double stranded breaks 
Double stranded break (DSB) incidence was quantified by 
counting γH2AX-positive foci-containing cells, where only cells with 2 or 
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more γH2AX foci are considered positive and included, as sporadic 
incidence of DSBs is a normal consequence of mammalian cell culture. 
AcGFP-progerin expressing cells were frequently observed to have more 
than 20 of such foci. Figure 3A shows an example of a quantified image, 
with a high incidence of DSBs in AcGFP-progerin-expressing CMs 
compared to control and AcGFP-expressing CMs. Transduction 
efficiencies for AcGFP and AcGFP-progerin were 55.0% and 53.3% 
respectively (Figure 3B). Incidence of γH2AX foci in control cells was 
10.5%, while incidence in the cells in the AcGFP images was 12.1% and 
12.35%, respectively for AcGFP-negative and AcGFP-positive foci. 
Interestingly, AcGFP-progerin images showed an increase in cells with 
foci for both AcGFP-progerin-positive (53.3%) and -negative cells 
(20.3%).  
 
Transgene expression in a conditional CMC promoter  
To validate our findings using direct transduction of CMs, we have 
chosen to develop a model that allows conditional expression of AcGFP-
progerin; the set-up of the viral vector is shown in figure 4a. Figure 4B 
displays the expression of the vector in mixed cultures, after culture for 
34DIV. At this time point, CMs are active and contract as evidenced by 
analysis with difference tracker (Figure 4C). The highlighted section at 
7.75s is an overlay with the moving pixels in the image, indicating the 
contraction of cells in red. To select individual clones for further analysis, 
we decided to screen integration sites using a qPCR assay on genomic 
DNA. For this purpose, previously puromycin-selected transduced 
HUES9 cells were single cell sorted and cultured after which gDNA was 
extracted. Optimal primer conditions and gDNA input were determined 
and AcGFP integration was normalized to genomic GAPDH content. From 
our data we selected two AcGFP and two AcGFP-progerin clones which 




Figure 3. AcGFP-progerin expression leads to increased DSB incidence. (A) 
Corresponding images of control and AcGFP (green) and AcGFP-progerin 
(green) transduced cells. A γH2AX staining is presented in the red channel, and 
Hoechst is depicted in blue.  Scalebar represents 25 µm. (B) Transduction 
efficiency in CMs is presented as AcGFP positive (green) and negative cells 
(blue). (C) Occurrence of DSBs as assessed by the percentage of cells containing 
2 or more γH2AX positive foci is more frequent in AcGFP-progerin-transduced 
cells compared to control and AcGFP-transduced cells. Non-transduced cells 
present in the progerin condition also display an increase in γH2AX foci. Data 




Figure 4. AcGFP-progerin can be expressed under the αMHC promoter in 
CMs. (A) Viral vector map of pSF-OxG-Lenti-aMHC-AcGFP-(Progerin)-Puro-
WPRE. AcGFP-progerin is placed under control of the α-MHC promoter, and 
flanked by an EF1α-PuroR cassette. (B) CMC cultures successfully express 
AcGFP-progerin (green) under the α-MHC promoter at 30DIV. The observed 
heterogeneity is the result of culturing a non-clonal cell population. (C) CMC 
cultures are functional at 30DIV, as evidenced by contraction highlighted by 
difference tracker. Bar represents 25 µm. (D) AcGFP integration normalized to 
GAPDH for AcGFP and AcGFP-progerin transduced HUES9 ESCs. Selected 





AcGFP-progerin can be expressed under the conditional α-MHC 
promoter in CMs 
Figure 5A demonstrates the expression of AcGFP-progerin (white) 
in a cardiomyocytes culture. Alpha-actinin (green) staining shows the 
sarcomeric structure of CMs, with co-localizing expression of troponin-T 
(red). Expression of LAMINA/C is illustrated in Figure 5B, and shows co-
localisation with AcGFP-progerin, indicating correct nuclear localisation. 
A staining with the gap junction protein Connexin-43 (Cx43) highlights the 
connections between adjacent cells. A mitochondrial TOMM20 (red) 
staining in Figure 5C displays no apparent defects in mitochondrial 
integrity in AcGFP-progerin (green) expressing cells. Although γH2AX 
(white) positive foci were occasionally observed in AcGFP-progerin 
expressing cells, their frequency was low.  
 
Neuronal AcGFP-progerin expression results in increased levels of 
α-synuclein 
To use our progerin expression model system in neuronal cells, 
we used the earlier described pSinEF2-AcGFP-progerin vector for direct 
transduction of differentiated cultures. Transgenic expression was 
achieved at 60DIV and maintained for 30DIV in purified neuronal cultures. 
This resulted in a marked increase of the amount of α-synuclein 
fluorescence when compared to AcGFP control. Expression of AcGFP-
progerin in differentiated PD patient iPSCs led to increased levels of α-
synuclein in these cells as assessed by confocal microscopy (Figure 6). 
Figure 6A shows expression of the AcGFP control vector, combined with 
TH (red), α-synuclein (yellow) and Hoechst (blue). Figure 6B shows 
expression of the AcGFP-progerin vector, combined with TH (red), α-






Figure 5. CMs confocal microscopy highlights functional characteristic. (A) 
CMs express striated α-actinin (red) structures and a structural distribution of 
troponin-T (green). AcGFP-progerin and Hoechst are presented in white and blue 
respectively. (B) CMs express laminA/C, which shows overlap with the AcGFP-
progerin signal (green). Connexin43 staining highlights the gap junctions 
between CMs, and Hoechst is depicted in blue. (C) CMs show no abnormalities 
in mitochondrial networks as evidenced by TOMM20 (red). γH2AX foci (white) 
were present, but not frequently observed. AcGFP-progerin and Hoechst are 
presented in white and blue respectively. Bar represents 25 µm. 
 
Figure 6. DA neurons expressing AcGFP-progerin have increased levels of 
α-synuclein.  
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(A) PD4 iPSC-derived DA neuron expressing AcGFP (green), stained for TH 
(red), α-synuclein (yellow) and Hoechst (blue). (B) PD4 iPSC-derived DA neuron 
expressing AcGFP-progerin (green), stained for TH (red), α-synuclein (yellow) 
and Hoechst (blue). Comparison of α-synuclein-associated fluorescence shows 
a marked increase between AcGFP and AcGFP-progerin transduced iPSC-
derived DA neurons. Bar represents 25 µm. 
 
Discussion and conclusion 
In this chapter, we successfully recapitulated ageing hallmarks by 
inducing overexpression of progerin in both neuronal and cardiac cells. 
The lentiviral approach allowed us to induce transgenic expression of 
progerin for prolonged periods of time (>30DIV). Our model recapitulates 
hallmarks of ageing which could not be produced by the approach of Miller 
et al. [15]. However, a downside of our viral approach is the uncontrolled 
integration of the viral vector, which can interfere with gene integrity and 
expression. This is solved by using a large population of post-mitotic cells, 
that will create a heterogeneous profile of viral integrates, effectively 
diluting any negative effects of viral integration. In our conditional 
promoter approach, however, viral integration might produce a problem 
since we are using clonal cells. To prevent harmful viral integration in 
these models, a non-restrictive linear amplification-mediated PCR should 
be performed to identify integration sites [22].  
 
The occurrence of increased oxidative stress and the increase in 
γH2AX-positive foci indicates that our model captures both genomic 
instability and mitochondrial dysfunction. Interestingly, mitochondrial ROS 
production is significant but not as pronounced compared to other model 
systems. Over two-fold increases in ROS generation are common when 
exposing cells to mitochondrial toxins like rotenone or paraquat, but our 
approach reports an increase of only 19.4%. In this light, our model 
recaptures more physiological levels of ROS increase that might lead to 
cellular damage over time. Mitochondrial abnormalities were not apparent 
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in confocal microscopy and it remains to be investigated whether the 
mitochondrial membrane potential is affected. The ability to induce long-
term mitochondrial toxicity by nuclear stress provides an indirect 
mechanism for manipulating mitochondrial function and so provides a 
relevant tool for studying mitochondrial function in ageing. Mitochondrial 
function will be further analysed in mitochondrial respiration and glycolysis 
assays using the Agilent Seahorse XF Technology, as oxidative 
phosphorylation has been proposed to be progressively impaired during 
ageing [23].   
The increase in γH2AX was an expected effect in progerin 
pathology. The large number of foci present in some of the cells point to 
extensive nuclear instability. Surprisingly, non-transduced cells in the 
progerin-transduced cultures also presented a higher number of foci 
indicating that an indirect effect may contribute to nuclear pathology. The 
overall increase in ROS production in these cultures might increase the 
indirect formation of DSBs in non-transduced cells [24] or might be the 
result of senescent paracrine signalling by progerin transduced cells [25].  
In human iPSC derived DA neurons, progerin-induced ageing in 
resulted in higher levels of α-synuclein compared to controls. The 
underlying cause for this increase remains to be investigated, but might 
stem from altered proteostasis in these neurons. Another option is the 
induction of aggregation by increased oxidative stress, which has a direct 
effect on α-synuclein oligomerization [26, 27]. It should be noted that while 
progerin can be used as an ageing model in these cells, neurons do not 
express Lamin-A or progerin in vivo [28]. Progerin induced ageing might 
therefore not be as physiologically relevant to the brain as it is to other 
organs, i.e. cardiomyocytes. It does, however, represent a model that 
recaptures multiple hallmarks of ageing.  
In summary, we present an alternative method to age cells, and 
show that functional CMs generated from HUES9 ESCs exposed to this 
method exhibit several characteristics of aging. Future experiments will 
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rely on a conditional promoter approach, and will validate earlier findings 
done in directly transduced CMs.  
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